Fundraising Fox
/Companies
Sign in

Theianova

4 employees on LinkedIn · 1 known investors

Find your way into Theianova

Each arrow is one introduction. Sign up to fill in the first one.

187 people can intro you to Carissa

Ask Kathryn de Ridder to introduce you to Carissa Fonseca

You →Kathryn · together at Theianova →Carissa

93 people can intro you to Priyanka

Ask Jamie Chen to introduce you to Priyanka Agarwal

You →Jamie · together at University of Auckland →Priyanka

Sign up to find every way you can get introduced to Theianova

  • Your email: who you already know at Theianova, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Theianova team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

BiotechHealthtechMedical Devices

Founders & leadership

CG
Colin GreenChief Scientific Officer
CFCarissa Fonseca
Carissa FonsecaChief Executive OfficerCarissa Fonseca holds a PhD in cardiovascular MRI and has worked in medical affairs roles covering diagnostic imaging, anesthesia, and sedation, with experience spanning basic science through clinical trials and industry engagement with key opinion leaders across imaging modalities and anesthesia.
PAPriyanka Agarwal
Priyanka AgarwalDirector of Research & Operations, Formulation LeadPriyanka Agarwal is Director of Research & Operations and Formulation Lead at TheiaNova, a biotech developing corneal therapeutics. She brings pharmaceutical development experience from both industry and academic roles, with expertise in ocular drug delivery, formulation development, and controlled release systems.

Investors · 1

Frequently asked questions

What does Theianova do?
TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.
Who founded Theianova?
Theianova was founded by Colin Green.
Who are Theianova's investors?
Theianova's investors include Bridgewest Ventures.